Zimmer Biomet Holdings Inc. (ZBH)

ZBH · Health Care · United States

Zimmer Biomet Holdings Inc. (ZBH) is a company in the Health Care sector, based in United States. The stock is held in 22 ETFs we track – with its largest weight of 0.31 % in XUHL (msci-usa-health-care). Anyone holding one of these ETFs also owns a small indirect stake in Zimmer Biomet Holdings.

Above-average ETF coverage: 22 of the 95 ETFs we cover hold Zimmer Biomet Holdings, spread across 10 indices. That puts the stock in more ETFs than 87.9 % of the 4,334 stocks we cover.

Held in22 ETFs

Highest weight0.31 %

Indices10

SectorHealth Care

CountryUnited States

ISINUS98956P1021

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date	+7.6 %	1 year	-2.4 %
1 month	-1.4 %	3 months	+11.0 %
Calendar year 2025	-14.9 %

52W

Data note 3

Measured in euros, Zimmer Biomet Holdings returned +9.6 % year to date and -0.1 % over one year. The gap to the dollar figures above comes from the exchange rate alone: each daily price is converted at the ECB euro reference rate for the same day.

Data note 4

Risk metrics

Max drawdown-31.5 %

Volatility p.a.29.6 %

Data note 5

Below peak-16.7 %

Beta to S&P 5000.22

Correlation to S&P 5000.09

The close on Sep 16, 2026 was 16.7 % below the highest close since Aug 12, 2024, reached on Sep 3, 2024. Over the last 252 trading days, on days when the S&P 500 rose or fell 1 %, Zimmer Biomet Holdings moved on average 0.22 % in the same direction. The correlation of 0.09 shows how reliable that average is: the broad market explained only a small share of the daily moves.

Data note 6

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Correlated with
Instrument	r	−1 … +1
Stryker Corporation	+0.74
Medtronic Plc	+0.67
STERIS plc	+0.66
Solventum Corporation	+0.60
Camden Property Trust REIT	+0.55
IDEXX Laboratories Inc.	+0.54
Seagate Technology Holdings plc	-0.44
Jabil Inc.	-0.42
Lam Research Corporation	-0.41

Data note 7

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.

Revenue8.2 bn $

Net income0.7 bn $

Diluted EPS3.55 $

Net margin8.6 %

Return on equity5.6 %

Equity ratio55.0 %

Revenue growth+7.2 %

Revenue and profit by fiscal year
Fiscal year	Revenue	Net income	Margin
FY2023	7.4	1.0	13.8 %
FY2024	7.7	0.9	11.8 %
FY2025	8.2	0.7	8.6 %

Data note 8

Held in these ETFs

Held in these ETFs
ETF	Index	Weight	per €1,000 in the ETF
XUHL / XUHC	msci-usa-health-care	0.31 %	€3.10
XDWH	msci-world-health-care	0.22 %	€2.20
SPFS	msci-world-health-care	0.22 %	€2.20
XDEV	msci-world-value	0.12 %	€1.20
WVAL	msci-world-value	0.09 %	€0.90
2B7K	msci-world-sri	0.09 %	€0.90
SPYI / SPSA	msci-acwi-imi	0.05 %	€0.50
SPYL / SPY5	sp500	0.03 %	€0.30
SXR8	sp500	0.03 %	€0.30
XD9U / XD9D	msci-usa	0.03 %	€0.30
SWWD	msci-world	0.02 %	€0.20
WIMI	msci-world-imi	0.02 %	€0.20
SPYY	msci-acwi	0.02 %	€0.20
EUNL	msci-world	0.02 %	€0.20
IUSQ	msci-acwi	0.02 %	€0.20
SPPW	msci-world	0.02 %	€0.20
XDWD / XDWL	msci-world	0.02 %	€0.20

Data note 9

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Zimmer Biomet Holdings as of the fund's latest holdings list.

Weight in EUNL since 2019

Sep 30, 2019Sep 16, 2026

In EUNL, a fund tracking the MSCI World, Zimmer Biomet Holdings had a weight of 0.06 % on Sep 30, 2019 and 0.02 % on Sep 16, 2026. Its share peaked at 0.06 % on Sep 30, 2019. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 10

How much Zimmer Biomet Holdings Inc. overlaps with other holdings in a portfolio is shown by the Portfolio X-Ray and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Zimmer Biomet Holdings — the figure counts the ETFs holding both.

Data note 11

Key figures side by side

Key figures compared with stocks of similar ETF exposure
Stock	1 year	Volatility p.a.	Net margin	Revenue growth
Zimmer Biomet Holdings	-2.4 %	29.6 %	8.6 %	+7.2 %
Cooper Companies	-16.2 %	33.6 %	9.2 %	+5.1 %
Cigna Group	-4.7 %	30.7 %	2.2 %	+11.2 %
Elevance Health	+33.1 %	35.3 %	2.8 %	+12.5 %
Biogen	+50.3 %	32.2 %	13.1 %	+2.2 %
Labcorp Holdings	+18.4 %	23.1 %	6.3 %	+7.2 %
Pfizer	+14.9 %	24.1 %	12.4 %	-1.6 %
Centene Corporation	+107.6 %	51.4 %	-3.8 %	+20.0 %
Incyte Corporation	+48.7 %	34.3 %	25.0 %	+21.2 %

Return and volatility from our daily closing prices in US dollars; margin and growth from the latest SEC annual filing. Fiscal years do not all end on the same date.